Presentations to highlight preclinical data supporting the clear differentiation of Adcentrx's clinical-stage ADRX-0405 STEAP1 ADC and preclinical ADRX-0134 NaPi2b ADC SAN DIEGO, March 25, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company...
Read More Details
Finally We wish PressBee provided you with enough information of ( Adcentrx Therapeutics to Showcase Novel STEAP1 and NaPi2b ADCs with Oral and Poster Presentations at AACR 2025 )
Also on site :
- Mel Owens' Ex-Wife Issues Bold Statement on His Upcoming 'Golden Bachelor' Season: 'It's Going to be Bad'
- European retailer inspired by ‘new Med’ hits major milestone opening its 50th store in the US – and 15 more are coming
- Al menos 9 personas muertas y 15 heridas por caída de un autobús a un río en México